- Home
- ASRT vs PYXS Comparison
ASRT vs PYXS Comparison
Compare ASRT & PYXS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ASRT
- PYXS
- Stock Information
- Founded
- ASRT 1995
- PYXS 2018
- Country
- ASRT United States
- PYXS United States
- Employees
- ASRT N/A
- PYXS N/A
- Industry
- ASRT Biotechnology: Pharmaceutical Preparations
- PYXS Biotechnology: Pharmaceutical Preparations
- Sector
- ASRT Health Care
- PYXS Health Care
- Exchange
- ASRT Nasdaq
- PYXS Nasdaq
- Market Cap
- ASRT 85.1M
- PYXS 101.1M
- IPO Year
- ASRT 1997
- PYXS 2021
- Fundamental
- Price
- ASRT $0.83
- PYXS $1.50
- Analyst Decision
- ASRT Strong Buy
- PYXS Strong Buy
- Analyst Count
- ASRT 4
- PYXS 8
- Target Price
- ASRT $3.19
- PYXS $9.43
- AVG Volume (30 Days)
- ASRT 634.7K
- PYXS 817.5K
- Earning Date
- ASRT 03-10-2025
- PYXS 11-12-2024
- Dividend Yield
- ASRT N/A
- PYXS N/A
- EPS Growth
- ASRT N/A
- PYXS N/A
- EPS
- ASRT N/A
- PYXS N/A
- Revenue
- ASRT $125,763,000.00
- PYXS $16,146,000.00
- Revenue This Year
- ASRT N/A
- PYXS N/A
- Revenue Next Year
- ASRT $1.84
- PYXS N/A
- P/E Ratio
- ASRT N/A
- PYXS N/A
- Revenue Growth
- ASRT N/A
- PYXS N/A
- 52 Week Low
- ASRT $0.73
- PYXS $1.39
- 52 Week High
- ASRT $1.80
- PYXS $6.85
- Technical
- Relative Strength Index (RSI)
- ASRT 42.81
- PYXS 36.16
- Support Level
- ASRT $0.78
- PYXS $1.39
- Resistance Level
- ASRT $0.94
- PYXS $1.82
- Average True Range (ATR)
- ASRT 0.05
- PYXS 0.10
- MACD
- ASRT -0.00
- PYXS 0.03
- Stochastic Oscillator
- ASRT 29.56
- PYXS 25.58
About ASRT Assertio Holdings Inc.
Assertio Holdings Inc is a pharmaceutical company. It is engaged in providing solutions to advance patient care in the areas of neurology, orphan and specialty medicines. The company markets three FDA-approved products for various neurological conditions including Gralise, tablets for the management of postherpetic neuralgia; CAMBIA, for acute treatment of migraine attacks with or without aura in adults of age or older; and Zipsor, liquid-filled capsules for relief of mild to moderate pain.
About PYXS Pyxis Oncology Inc.
Pyxis Oncology Inc is a preclinical oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients. It develops the product candidates with the objective to directly kill tumor cells, and to address the underlying pathologies created by cancer that enable its uncontrollable proliferation and immune evasion.